Abbott Laboratories buy Jefferies Financial Group Inc.
Start price
16.10.25
/
50%
€110.74
Target price
16.10.26
€127.63
Performance (%)
-17.46%
Price
20.03.26
€91.40
Summary
This prediction is currently active. The prediction for Abbott Laboratories disappoints with a performance of -17.46%. This prediction currently runs until 16.10.26. The prediction end date can be changed by Jefferies_Financial_ at any time. Jefferies_Financial_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Abbott Laboratories | -3.413% | -3.413% |
| iShares Core DAX® | -4,93 % | -11,98 % |
| iShares Nasdaq 100 | -2,63 % | -2,22 % |
| iShares Nikkei 225® | -4,73 % | -10,90 % |
| iShares S&P 500 | -2,54 % | -3,54 % |
Comments by Jefferies_Financial_ for this prediction
In the thread Discuss Abbott Laboratories
Abbott Laboratories (NYSE:ABT) had its price target raised by analysts at Jefferies Financial Group Inc. from $145.00 to $149.00. They now have a "buy" rating on the stock.
Ratings data for ABT provided by MarketBeat
Stopped prediction by Jefferies_Financial_ for Abbott Laboratories
Abbott Laboratories
Start price
Target price
Perf. (%)
€104.68
18.07.25
18.07.25
€124.73
18.07.26
18.07.26
-12.69%
20.03.26
20.03.26
